Skip to Main Content

Author Details

Kjetil Boye
Oslo University Hospital
2007
70
26
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36724411Genomic Complexity as a Biomarker to De-Escalate Adjuvant Imatinib Treatment in High-Risk Gastrointestinal Stromal Tumor.JCO Precis Oncol2023
37598656Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study.Eur J Cancer2023
37622176Chromosomal instability and a deregulated cell cycle are intrinsic features of high-risk gastrointestinal stromal tumours with a metastatic potential.Mol Oncol2023
37643281Sarcoma care in the era of precision medicine.J Intern Med2023
34560242Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol2022
35698755Real-world evidence on perioperative chemotherapy in localized soft tissue sarcoma of the extremities and trunk wall; a population-based study.Acta Oncol2022
36030294Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour.Br J Cancer2022
35284037Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity.Oncotarget2022
34049768Metastases in locally advanced rectal cancer undergoing curatively intended treatment.Eur J Surg Oncol2021
33829360Correction to: ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?Ann Surg Oncol2021
33651216Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the Stomach.Ann Surg Oncol2021
33580363Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial.Cancer Immunol Immunother2021
33745702Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour.Pathology2021
33687615ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?Ann Surg Oncol2021
34500044Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.Ann Oncol2021
34303806Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>â¿¿</sup>.Ann Oncol2021
34090171Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts.ESMO Open2021
34050156Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden.Nat Commun2021
32208873Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction study.Acta Oncol2020
31703948Cell-free DNA in blood as a noninvasive insight into the sarcoma genome.Mol Aspects Med2020
31991494A novel risk score to predict early and late recurrence in solitary fibrous tumour.Histopathology2020
32098573Neoadjuvant chemotherapy is associated with a transient increase of intratumoral T-cell density in microsatellite stable colorectal liver metastases.Cancer Biol Ther2020
33322371Prospects for NK Cell Therapy of Sarcoma.Cancers (Basel)2020
32616718Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS).Sci Rep2020
32447231Experimental Treatment of Mucinous Peritoneal Metastases Using Patient-Derived Xenograft Models.Transl Oncol2020
30507040Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour.Br J Surg2019
30207179Pazopanib in relapsed osteosarcoma patients: report on 15 cases.Acta Oncol2019
28754721Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma.Oncologist2018
29800950Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series.JAMA Oncol2018
30097488Noninvasive Detection of ctDNA Reveals Intratumor Heterogeneity and Is Associated with Tumor Burden in Gastrointestinal Stromal Tumor.Mol Cancer Ther2018
30277049Multimodal kreftbehandling av gastrointestinal stromal tumor.Tidsskr Nor Laegeforen2018
29691115Beyond total mesorectal excision in locally advanced rectal cancer with organ or pelvic side-wall involvement.Eur J Surg Oncol2018
29435684Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study.Ann Surg Oncol2018
29341147Genotype and risk of tumour rupture in gastrointestinal stromal tumour.Br J Surg2018
28061772Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report.BMC Cancer2017
28105885Denosumab in patients with giant-cell tumor of bone in Norway: results from a nationwide cohort.Acta Oncol2017
28557540Prediction of long-term survival in patients with metastatic gastrointestinal stromal tumor: analysis of a large, single-institution cohort.Acta Oncol2017
28761742Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate.ESMO Open2017
28058579Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer.Breast Cancer Res Treat2017
27766561Deep Pelvic Surgical Site Infection After Radiotherapy and Surgery for Locally Advanced Rectal Cancer.Ann Surg Oncol2017
27815616Estimated cumulative radiation dose received by diagnostic imaging during staging and treatment of operable Ewing sarcoma 2005-2012.Pediatr Radiol2017
26039107F-18-FDG PET-CT in children and young adults with Ewing sarcoma diagnosed in Norway during 2005-2012: a national population-based study.Clin Physiol Funct Imaging2016
27999655Clinical implications of repeated drug monitoring of imatinib in patients with metastatic gastrointestinal stromal tumour.Clin Sarcoma Res2016
27273130Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy.Cancer Med2016
27220319Expression and clinical significance of Wee1 in colorectal cancer.Tumour Biol2016
27316334Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer.Diagn Pathol2016
26888115Oxaliplatin-containing Preoperative Therapy in Locally Advanced Rectal Cancer: Local Response, Toxicity and Long-term Outcome.Clin Oncol (R Coll Radiol)2016
26988241Definition and clinical significance of tumour rupture in gastrointestinal stromal tumours of the small intestine.Br J Surg2016
25466510High expression of the cysteine proteinase legumain in colorectal cancer - implications for therapeutic targeting.Eur J Cancer2015
26349943Enrichment of nuclear S100A4 during G2/M in colorectal cancer cells: possible association with cyclin B1 and centrosomes.Clin Exp Metastasis2015
  • 1 - 50 of 70

Recommended Authors

Institut de Pathologie Multisite
Career Start Year 2013
Number of shared co-authors 0
Singapore General Hospital
Career Start Year 2010
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2008
Number of shared co-authors 0
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Career Start Year 2008
Number of shared co-authors 0
University of California-Los Angeles
Career Start Year 2006
Number of shared co-authors 0
Tisch Cancer Institute, Mount Sinai Hospital
Career Start Year 2005
Number of shared co-authors 0
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 1
College of Big Data & Software Engineering, Chongqing University
Career Start Year 2005
Number of shared co-authors 0
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Diagnostic and Research Institute of Pathology, Medical University of Graz
Career Start Year 2003
Number of shared co-authors 21
Lund University
Career Start Year 2003
Number of shared co-authors 0
Goldman School of Medicine, Ben Gurion University
Career Start Year 2001
Number of shared co-authors 0
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 1
Samsung Medical Center, Sungkyunkwan University
Career Start Year 2001
Number of shared co-authors 0
Tianjin Medical University Cancer Institute and Hospital
Career Start Year 2000
Number of shared co-authors 1
University of Texas MD Anderson Cancer Center
Career Start Year 2000
Number of shared co-authors 1
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 1
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 0
University Claude Bernard Lyon I
Career Start Year 1997
Number of shared co-authors 7
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1997
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
University of California San Diego Moores Cancer Center
Career Start Year 1992
Number of shared co-authors 2
Institute of Pathology, Heidelberg University Hospital
Career Start Year 1991
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 6
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 2
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 1
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Career Start Year 1988
Number of shared co-authors 3
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 1
Oregon Health & Science University
Career Start Year 1985
Number of shared co-authors 6

Collaborators

The Norwegian Radium Hospital, Oslo University Hospital
Co-authored papers 8
Center for Bioinformatics, University of Oslo
Co-authored papers 5
Medical University of Graz
Co-authored papers 5
Institute for Cancer Research, Oslo University Hospital
Co-authored papers 5
Fondazione IRCSS Istituto Nazionale dei Tumori
Co-authored papers 4
Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.
Co-authored papers 4
Co-authored papers 4
University College London, Cancer Institute
Co-authored papers 3
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 3
Royal Manchester Children's Hospital
Co-authored papers 3
University of Oslo
Co-authored papers 3
Institute for Cancer Research, Oslo University Hospital
Co-authored papers 2
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 2
University of Oslo
Co-authored papers 2
Institute for Cancer Research, Oslo University Hospital
Co-authored papers 2
Institute for Cancer Research, Oslo University Hospital
Co-authored papers 2
Institut Curie
Co-authored papers 1
Balgrist University Hospital, University of Zurich (UZH)
Co-authored papers 1
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Co-authored papers 1
St. Anna Children's Cancer Research Institute (CCRI)
Co-authored papers 1
University Hospital Erlangen
Co-authored papers 1
Faculty of Clinical Medicine, University of Oslo
Co-authored papers 1
INSERM U830 Cancer, Institut Curie Research Center, PSL Research University
Co-authored papers 1
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1
Sylvester Comprehensive Cancer Center, University of Miami
Co-authored papers 1
Children's Cancer Research Institute
Co-authored papers 1
St. Anna Children's Cancer Research Institute
Co-authored papers 1
University Hospital Erlangen
Co-authored papers 1
Broad Institute
Co-authored papers 1